History

1981

Founding of the company, which acts as a “Broker” and “Procurement Officer” on behalf of large NGOs and European organisations that are active in the Development and Health sectors.

1983

Beginning of the trading activity, exphar becomes wholesaler/distributor for export.

1986

The company comprises three divisions:

  • Pharma development division, exphar public limited
  • Pharmaceutical distribution division, creation of “Medexport Ltd.”
  • Pharmaceutical engineering division, creation of “Pharmatech Ltd.”
1987

Development of the first “sociality”, Maloxine® and marketing in East and Central Africa.

1990

Maloxine® is the first product sold on volume in Nigeria.

1995

exphar integrates the French-speaking West Africa market (CFA zone) and introduced several of its socialities there.

1999

exphar‘s range of socialities grows and is marketed in 20 countries in Africa, Asia and Central America.

2000

Launch of Verzol® which will quickly become a best-seller in Sub-Saharan Africa.

2005

Launch of the PROGEN product range, Total Quality generics.

2011

EUGMP Certification of production sites – exphar makes production quality a priority.

2015

Regional offices merge into a single new logistics center in Nivelles, Belgium.

2017

exphar is among the top 10 laboratories in Sub-Saharan Africa and the top 5 in terms of units sold.

2018

Launch of our subsidiary in Nigeria.

2019

Launch of a subsidiary in Rwanda and opening of a distribution center in Kigali.

2021

exphar celebrates its 40th anniversary and markets 50 products in 25 countries in Africa, Asia and Central America.